Inventor · disambiguated record
Bernard Lethe
Also filed as: LETHE BERNARD
15 granted patents·306 citations·filing 1993–2009
93Inventor score
Top patents by PatentIndex Score
15 records- 0190US5612201AIsolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursorLUDWIG INST CANCER RES·Filed 1994·Granted Mar 18, 1997·127 cites·3 claims
- 0279US6669946B2Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individualsLUDWIG INST CANCER RES·Filed 2001·Granted Dec 30, 2003·5 cites·1 claims
- 0379US5487974AMethod for detecting complexes containing human leukocyte antigen A2 (HLA-A2) molecules and a tyrosinase drived peptide on abnormal cellsLUDWIG INST CANCER RES·Filed 1993·Granted Jan 30, 1996·59 cites·6 claims
- 0474US7998483B2Lage-1 tumor associated nucleic acidsLUDWIG INST FOR CANCER RES LTD·Filed 2009·Granted Aug 16, 2011·0 cites·4 claims
- 0569US5744316AIsolated, tyrosinase derived peptides and uses thereofLUDWIG INST CANCER RES·Filed 1996·Granted Apr 28, 1998·28 cites·10 claims
- 0667US7563870B2LAGE-1 tumor associated nucleic acidsLUDWIG INST FOR CANCER RES LTD·Filed 2004·Granted Jul 21, 2009·0 cites·6 claims
- 0766US5530096AIsolated, tyrosinase derived peptides and uses thereofLUDWIG INST CANCER RES·Filed 1994·Granted Jun 25, 1996·22 cites·1 claims
- 0864US6716809B1Mage-A3 peptides presented by HLA class moleculesLUDWIG INST CANCER RES·Filed 1999·Granted Apr 6, 2004·15 cites·14 claims
- 0957US5763155AMethod for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3 gene productsLUDWIG INST CANCER RES·Filed 1996·Granted Jun 9, 1998·16 cites·2 claims
- 1050US5763165AMethod for determining lung adenocarcinomas by assaying for one or more of MAGE-1, MAGE-2 and MAGE-3LUDWIG INST CANCER RES·Filed 1994·Granted Jun 9, 1998·14 cites·11 claims
- 1144US5512437AMethod for determining head and neck squamous cell carcinomas, prostate carcinomas, and bladder tumors by assaying for mage-3LUDWIG INST CANCER RES·Filed 1994·Granted Apr 30, 1996·11 cites·11 claims
- 1243US7157091B1MAGE-A1 peptides presented by HLA class II moleculesLUDWIG INST CANCER RES·Filed 1999·Granted Jan 2, 2007·4 cites·8 claims
- 1341US6794131B1Lage-1 tumor associated nucleic acidsLUDWIG INST CANCER RES·Filed 1998·Granted Sep 21, 2004·3 cites·10 claims
- 1441US5843688AIsolated tyrosinase derived peptides and uses thereofLUDWIG INST CANCER RES·Filed 1996·Granted Dec 1, 1998·2 cites·3 claims
- 1529US6284476B1Method of identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen/tyrosinase derived peptides, and methods for treating said individualsLUDWIG INST CANCER RES·Filed 1995·Granted Sep 4, 2001·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Bernard Lethe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →